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Our aim was to compare the eﬀects of goal-directed therapy guided either by pulmonary artery catheter (PAC) or by transpul-
monary thermodilution (TTD) combined with monitoring of oxygen transport on perioperative hemodynamics and outcome
after complex elective valve surgery. Measurements and Main Results. Forty patients were randomized into two equal groups:
a PAC group and a TTD group. In the PAC group, therapy was guided by mean arterial pressure (MAP), cardiac index (CI)
and pulmonary artery occlusion pressure (PAOP), whereas in the TTD group we additionally used global end-diastolic volume
index (GEDVI), extravascular lung water index (EVLWI), and oxygen delivery index (DO2I). We observed a gradual increase
in GEDVI, whereas EVLWI and PAOP decreased by 20–30% postoperatively (P<0.05). The TTD group received 20% more
ﬂuid accompanied by increased stroke volume index and DO2I by 15–20% compared to the PAC group (P<0.05). Duration
of mechanical ventilation was increased by 5.2hrs in the PAC group (P = 0.04). Conclusions. As compared to the PAC-guided
algorithm, goal-directed therapy based on transpulmonary thermodilution and oxygen transport increases the volume of ﬂuid
therapy, improves hemodynamics and DO2I, and reduces the duration of respiratory support after complex valve surgery.
1.Introduction
Valve repair and replacement is a rapidly progressing and
challenging type of cardiac surgery [1–3]. The outcome of
valve surgery is inﬂuenced by a variety of factors including
age and the general condition of the patient, preoperative se-
verity of heart dysfunction, myocardial ischemia, and dura-
tion of cardiopulmonary bypass (CPB) [4, 5]. The latter may
induce systemic inﬂammatory response syndrome (SIRS)
and lead to multiorgan dysfunction syndrome (MODS) [6–
10].
Several therapeutic approaches have been used to allevi-
ate CPB-induced SIRS and MODS including goal-directed
hemodynamicoptimization[11].Thus,complexmonitoring
could increase the eﬃcacy of these therapies. Recently, so-
called “less invasive” techniques for measurement of cardiac
output (CO) have been implemented as a useful adjunct
or even alternative to the hemodynamic monitoring by
means of the pulmonary artery catheter (PAC). Among these
various techniques, transpulmonary thermodilution, allow-
ing measurement of volumetric parameters and subsequent
continuous, “beat-to-beat” CO-computation based on pulse2 Critical Care Research and Practice
contour analysis, has proved to be a valuable monitoring tool
bothincoronarysurgeryandheartfailure[12–15].However,
its potential advantage in heart valve surgery in comparison
with pressure-oriented hemodynamic monitoring, which is
still widely used, has not been elucidated. This is especially
interestingwhentakingintoaccountthat,beforerepair,valve
diseases can distort the thermodilution curves, and thus, the
results of the measurements.
Severe SIRS and MODS triggered by major cardiosur-
gical intervention and/or CPB can also disturb the oxygen
transport. Hence, continuous measurement of either central
venous (ScvO2) or mixed venous (SvO2) oxygen saturation
may be a valuable adjunct to routine hemodynamic mon-
itoring, which allows the determination of oxygen delivery
andimprovestheoutcomeofseveralcategoriesofcriticallyill
patients [16, 17]. Recently introduced in clinical practice, the
combination of continuous monitoring of CO and oxygen
transport seems to be an attractive tool for displaying a
“global hemodynamic view” and subsequent goal-directed
perioperative optimization [18]. These algorithms have
demonstrated their feasibility in both on-pump [19]a n d
oﬀ-pump [15] coronary artery bypass grafting, but require
further investigation in valve repair and replacement.
Therefore, the aim of this study was to evaluate the eﬀect
oftreatmentalgorithmsguidedeitherbyPACorbytranspul-
monary thermodilution combined with monitoring of oxy-
gen transport on perioperative hemodynamic management
and outcome after complex valve surgery.
2.MaterialsandMethods
The study was approved by the Ethics Committee of North-
ern State Medical University, Arkhangelsk, Russia, in full
compliance with the ethical standards as proclaimed by
the Helsinki Declaration. Written informed consent was
obtained from all patients or legal surrogate.
Forty-three adult patients scheduled for elective replace-
ment/repair of two and more valves were enrolled into the
single-centre study performed in an 850-bed university hos-
pital during the period from March 2008 to June 2010. All
operations were performed by the same surgical team. The
inclusion criteria were age >18 years, presence of moderate
or severe valve regurgitation and/or stenosis, and scheduled
repair and/or replacement of two or more cardiac valves
requiring CPB. The patients were excluded from the study if
theyhadstenosisofcoronaryarteriesrequiringsimultaneous
coronary bypass grafting, extreme obesity (body mass index
>40kg m−1), or participation in other investigations. Before
the procedure, all patients were examined according to a
standard protocol; risk of surgery was evaluated using the
EuroSCORE system [20].
2.1. Clinical Protocol. On the day of surgery, patients were
randomized into two groups using unmarked, sealed en-
velopes. Three patients were excluded from the analysis
(Figure 1): two due to protocol violation (inability to reach
study goals postoperatively caused in one case by massive
blood loss and in another case—by PAC malfunction)
and one due to inadequate surgical correction diagnosed
by intraoperative transesophageal echocardiography (TEE).
The hemodynamic optimization in the PAC group (n = 20)
was targeted using parameters provided by PAC including
pulmonary arterial occlusion pressure (PAOP) and cardiac
index (CI) (LifeScope monitor, Nihon Kohden, Japan)
(Figure 2(a))( I nc a s e so faP A O P< 12mmHg, a 500mL
bolus of 6% hydroxyaethyl starch 130/0.42 (Venofundin, B |
Braun)wasinfusedover30minutesaimingataPAOPwithin
the range of 12–18mmHg. The bolus infusion could be
repeated once. If PAOP exceeded 18mmHg, nitroglycerin
and/or furosemide and/or dobutamine were used on clin-
ical judgment. If MAP was <60mmHg, an epinephrine
infusion was started at 0.05μgk g −1 min−1 with the option
to increase the dose in 0.05μgk g −1 min−1 increments, if
required. In case of hypertension (MAP > 100mmHg),
nitroglycerin infusion was administered in the dose range
of 0.5–3.0μgkg −1 min−1. A transfusion trigger was Hb <
8gdL −1. Heart failure and low cardiac output syndrome (CI
< 2.0 L min−1 m−2) required a dobutamine infusion start-
ing at 3.0μgkg −1 min−1. Central venous oxygen saturation
(ScvO2) was maintained >60%). In the group of transpul-
monary thermodilution, the TTD group (n = 20), hemody-
namics was managed using transpulmonary thermodilution
including CI, global end-diastolic volume index (GEDVI),
extravascularlungwaterindex(EVLWI),andoxygendelivery
index (DO2I) as measured with the PiCCO2 monitor (Pul-
sion Medical Systems, Munich, Germany) (Figure 2(b))( I n
cases where GEDVI < 680mm−2 and EVLWI < 10mLkg−1,
a 500mL bolus of 6% hydroxyaethyl starch 130/0.42 was
infused over 30 minutes aiming at a GEDVI within the
range of 680–850mLm−2. The bolus infusion could be
repeated. If GEDVI exceeded 850mLkg−1, nitroglycerin
and/or furosemide and/or dobutamine were given on clini-
c a lj u d g e m e n t .I nc a s eo fp u l m o n a r ye d e m a( E V L W I>
10mLkg−1), we used intravenous administration of fu-
r o s e m i d ea tad o s eo f2 0m g .I fM A Pw a s< 60mmHg, epi-
nephrine infusion was started at 0.05μgkgmin −1 with an
optional increment in dosage of 0.05μgkg −1 min−1.I nc a s e s
of hypertension (MAP > 100mmHg), nitroglycerin infusion
was given at a dose of 0.5–3.0μgk g −1 min−1. A transfusion
trigger was Hb < 8.0gdL−1. Heart failure and low cardiac
output syndrome (CI < 2.0 L min−1 m−2) were treated with a
dobutamine infusion starting at 3.0μgk g −1 min−1 aimed at
maintaining DO2I in the range of 400–600mLmin−1 m−2.
ScvO2 was maintained >60%). Mean arterial pressure
(MAP), heart rate (HR), and hemoglobin concentration
(Hb) were included into both the PAC- and the TTD-driven
protocols. In both groups, ScvO2 was maintained >60%.
The algorithms for perioperative goal-directed therapy are
depicted in Figure 2.
2.2. Anesthesia, Surgery, and Postoperative Care. All patients
received standard premedication with diazepam. After ar-
rival to the operation theatre, a femoral artery was catheter-
izedeitherwithstandard18Gcatheter(Arterioﬁx,B | Braun,
Germany) in the PAC-group or with a 5F thermodilution
catheter (PV2015L20 PULSOCATH, Pulsion Medical Sys-
tems) in the TTD group. After induction of anesthesia in
the PAC group, a central venous introducer (Intradyn 8F,Critical Care Research and Practice 3
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Figure 1: Flow diagram detailing the conduct of the study. PAC: pulmonary arterial catheter; TTD: transpulmonary thermodilution.
B | Braun) was inserted into the right internal jugular vein
followed by a PAC (7.5F, Corodyn, B | Braun). The position
of PAC and the adequacy of valve repair were veriﬁed by TEE
(Acuson Cypress, Siemens, Germany) performed after CPB.
In the TTD group, a triple-lumen central venous catheter
(Certoﬁx, B | Braun) and a ﬁbre-optic probe (PV 2022–37,
Pulsion Medical Systems) were inserted via the right jugular
vein for continuous oxygen transport monitoring. Central
venouspressure(CVP)wasmeasuredusingeitherthevenous
port of the PAC or the middle port of the triple-lumen
catheter in the PAC and the TTD groups, respectively.
Induction of anesthesia was performed with midazolam
0.07mg kg−1,p r o p o f o l1 . 0m gk g −1 and fentanyl 5–7μgkg −1
in both groups. Anesthesia was maintained by continuous
infusion of propofol (3–5mgkg−1hr−1) and fentanyl (4-
5μgkg −1hr−1). Muscular paralysis for tracheal intubation
was achieved by pipecuronium bromide 0.1mgkg−1 and
maintained with repeated doses of pipecuronium 0.015mg
kg−1hr−1 during operation. After intubation, volume-con-
trolledmechanicalventilation(FabiusGS,Dr¨ ager,Germany)
was provided with FiO2 0.5, tidal volume 7-8mLkg−1,p o s i -
tive end-expiratory pressure (PEEP) 5cm H2O, and respi-
ratory rate of 12–14min−1. For postoperative mechanical
ventilation, we used Evita 4 (Dr¨ ager, Germany), maintaining
a tidal volume of 7-8mLkg−1 and a PEEP of 5cm H2O.
Cardiopulmonary bypass was performed in nonpulsatile
mode with perfusion index of 3.0Lmin−1m−2 using a
standard roller-pump CPB-machine (Jostra HL 20, Maquet,
Sweden). The priming of the reservoir was similar in both
groups: 1000mL Ringer’s solution and 500mL Gelofusine
(B | Braun).Forcardiacarrestandmyocardialprotection,we
infused ice-cold (4–6◦C) cardioplegic solution (Custodiol,
Dr. F. Koehler Chemie GmbH, Germany) antegradely at an
initial dose of 20mL/kg. Restoration of cardiac function was
either spontaneous or facilitated by means of an epicardial
pacemaker. Weaning from CPB was performed in a stepwise
manner. In case of heart failure diagnosed as CI below
2.0Lmin−1m−2, we used dobutamine and/or epinephrine.
Fluid replacement included crystalloid solutions (Stero-
fundin Iso/G5, B | Braun) with an initial infusion rate
6-7mLkg−1hr−1 prior to and during anesthesia and 2-
3mLkg −1hr−1 postoperatively.
2.3. Measurements. In both groups, hemodynamic parame-
ters as well as arterial and central venous blood gases, arterial
hemoglobin, and lactate and glucose concentrations using
ABL800Flex (Radiometer, Denmark) were evaluated after
induction of anesthesia, at the end of surgery, and at 2, 6,
12, 18, and 24hrs postoperatively. These perioperative stages
were selected for goal-directed hemodynamic adjustments.
In addition, plasma samples were taken before surgery and
at 24hrs postoperatively for the determination of probrain
natriuretic peptide (NT-proBNP).
During the study, we evaluated perioperative ﬂuid ther-
apy, ﬂuid balance, and inotrope/vasoactive support. The
severity of postoperative MODS was estimated using the
SOFA score [21]. For assessment of clinical outcome, we
used duration of postoperative mechanical ventilation as the
primary end-point and the length of ICU and hospital stay,
and the mortality rate at Day 28 as the secondary end-points.
The clinician responsible for the weaning from ventilation,
ICUstay,andpatientdischargewasnotinvolvedinthestudy.
Criteriaforterminationofpostoperativerespiratorysup-
portwerethefollowing:acooperativepatient;adequatemus-
cular tone; SpO2 > 95% with FiO2 0.5; PaCO2 <45mmHg;4 Critical Care Research and Practice
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Figure 2: The algorithms of goal-directed hemodynamic optimization: (a) the PAC group, (b) the transpulmonary thermodilution (TTD)
group. CPB: cardiopulmonary bypass; MAP: mean arterial pressure; PAOP: pulmonary artery occlusion pressure; CI: cardiac index; GEDVI:
global end-diastolic volume index; EVLWI: extravascular lung water index; ScvO2: central venous oxygen saturation; DO2I: oxygen delivery
index; Hb: hemoglobin concentration; RBC: red blood cells; HAES: hydroxyaethyl starch.Critical Care Research and Practice 5
Table 1: Pre- and intraoperative characteristics of the study groups.
Parameter TTD group PAC group P value
Age, yrs 54 ± 12 54 ± 10 0.97
EuroSCORE, points 7 ± 37 ± 30 . 8 1
EuroSCORE, predicted mortality risk, % 7.5 (5.0–13.8) 10.5 (4.0–14.8) 0.65
NYHA, functional class of heart failure 3 ± 03 ± 10 . 1 9
Left ventricular ejection fraction before surgery, % 57 ± 11 57 ± 10 0.90
Duration of surgery, min 234 ± 47 229 ± 41 0.72
Duration of aortic cross-clamping, min 105 ± 31 109 ± 31 0.69
Duration of cardiopulmonary bypass, min 142 ± 43 142 ± 37 0.97
TTD: transpulmonary thermodilution; PAC: pulmonary artery catheter. Data are presented as mean ± SD or median (25th–75th percentiles).
postoperative bleeding rate <50mL hr−1; stable hemody-
namics without inotrope/vasopressor support; body temper-
ature of >35◦C. Temporary pacing was not regarded as a
contraindication for tracheal extubation.
Length of ICU stay was registered when the patient’s
condition met the following “ﬁt for discharge” criteria: fully
oriented, SaO2 > 90% on room air, no episodes of severe ar-
rhythmias,bleeding<50mLhr−1,diuresis>0.5mLkg−1hr−1,
no need for inotrope/vasopressor support, and no signs of
ischemia on ECG.
The patients were discharged from hospital when they
satisﬁed the following criteria: hemodynamic stability, inde-
pendence of ambulation and feeding, afebrile with no obvi-
ous infections, normal voiding and bowel movements, pain
control on oral medications, and exercise tolerance.
2.4. Statistical Analysis. The SPSS 15.0 software package was
used for statistical analysis. Calculation of sample size was
basedoninitialobservations(10casesineachgroup)andthe
hypothesis that TTD will shorten the time of postoperative
mechanical ventilation by 5hrs compared with the PAC
group. In order to ﬁnd a statistically signiﬁcant diﬀerence
with α of 0.05 and power of 0.8, a sample size of 20 patients
i ne a c hg r o u pp r o v e dt ob es u ﬃcient. Data were checked for
normal distribution by means of the Kolmogorov-Smirnov’s
test. Values are presented as mean ± standard deviation (SD)
ormedian(25th–75thpercentiles)forparametricallyornon-
parametrically distributed variables, respectively. In compli-
ance with the distribution of data, Student’s t-test or Mann-
Whitney’s U test were used for comparisons between groups.
Intragroup comparisons were performed using test of con-
trasts. Discrete data were analyzed by two-sided χ2-test or
Fisher’s exact test. For all tests, a P value < 0.05 was consid-
ered as signiﬁcant.
3. Results
As shown in Table 1, we found no intergroup diﬀerences
regarding demographic data, risk of surgery and severity of
chronic illnesses, severity of heart failure, preoperative ejec-
tion fraction, durations of surgery, aortic cross-clamping,
and CPB.
3.1. Hemodynamic Parameters. Table 2 demonstrates the
changes in hemodynamics. In both groups, CVP rose at the
end of surgery. Postoperatively, CVP declined transiently in
the PAC group (P<0.05) but returned to the baseline values
by 24hrs. In contrast, in the TTD group, CVP exceeded
the corresponding values of the PAC group at 6 and 18hrs
(P<0.05). In the TTD group, we observed a gradual post-
operative increase in GEDVI and stroke volume variations
(SVV) starting from 12 and 18hrs, respectively, whereas
EVLWI decreased by 20–30% (P<0.05). In the PAC group,
PAOP decreased signiﬁcantly after operation.
By the end of intervention, MAP and SVRI were higher
in the TTD group (Table 2; P<0.05). Postoperatively, MAP
a n dH Rr o s ei nb o t hg r o u p sw h e r e a sS V R Id e c r e a s e du n t i l
6hrs compared with the preoperative values (P<0.05). At
12hrs, SVRI increased in the PAC group (P = 0.03), but
decreased beyond 12hrs postoperatively in the TTD group.
As shown in Figure 3, CI rose postoperatively by 55% in
the TTD group and by 41% in the PAC group without inter-
group diﬀerence. In parallel, SVI and DO2I increased after
the operation in both groups. However, from 6hrs postop-
eratively SVI and DO2I were higher by 15–20% in the TTD
group (P<0.05).
3.2. Oxygenation/Laboratory Parameters. Oxygenation and
other laboratory data are shown in Table 3. Oxygenation
ratio (PaO2/FiO2) did not diﬀer signiﬁcantly between the
groups. At the end of surgery, PaO2/FiO2 decreased tran-
siently in the TTD group, whereas ScvO2 increased in
comparison with the preoperative values in the PAC group
(P<0.05). At 12hrs, ScvO2 was higher in the PAC group
(P = 0.012). After the intervention, pH decreased transiently
in parallel with a rise in plasma lactate and a decline in Hb in
both groups (P<0.05) without intergroup diﬀerences. Base
excess (BE) and PaCO2 did not diﬀer between the groups.
Postoperatively, we observed hyperglycemia, which was
more pronounced in the PAC group but without signiﬁcant
intergroup diﬀerence (Table 3). The plasma concentrations
of NT-proBNP rose postoperatively by 1045pgmL−1 and
1315pgmL−1 in the TTD and the PAC groups, respectively
(P>0.05). Preoperative serum creatinine concentrations
were 0.08 ± 0.02mmolL−1 and 0.09 ± 0.03mmolL−1 in6 Critical Care Research and Practice
Table 2: Changes in hemodynamic parameters in the study groups.
Group Before surgery End of surgery 2hrs 6hrs 12hrs 18hrs 24hrs
CVP, mm Hg TTD group 12 ± 41 6 ± 4† 11 ± 41 2 ± 4∗ 11 ± 51 3 ± 5∗ 14 ± 4
PAC group 13 ± 41 6 ± 3† 12 ± 41 0 ± 3† 10 ± 4† 11 ± 3† 12 ± 4
PAOP, mm Hg PAC group 19 ± 71 8 ± 61 5 ± 6† 13 ± 4† 12 ± 5† 15 ± 6† 16 ± 3
GEDVI, mL m−2 TTD group 757 ± 191 707 ± 63 719 ± 150 747 ± 106 815 ± 203† 824 ± 214† 839 ± 205†
SVV, % TTD group 8 ± 51 3 ± 51 3 ± 61 3 ± 51 4 ± 71 5 ± 5† 16 ± 6†
EVLWI, mL kg−1 TTD group 12 ± 41 1 ± 2† 10 ± 3† 9 ± 2† 10 ± 31 0 ± 3† 10 ± 2
MAP, mm Hg TTD group 73 ± 15 72 ± 13∗ 74 ± 15 71 ± 88 0 ± 11 87 ± 16† 88 ± 15†
PAC group 72 ± 17 66 ± 87 4 ± 11 71 ± 11 80 ± 11 87 ± 12† 82 ± 21
SVRI,
dyne·sec−1cm−5m−2
TTD group 2732 ± 738 1913 ± 564∗† 2093 ± 711† 1730 ± 443† 1948 ± 534∗† 2216 ± 692† 2073 ± 517†
PAC group 2610 ± 1039 1466 ± 411† 1962 ± 644† 2030 ± 618† 2345 ± 716 2493 ± 626 2286 ± 581
HR, min−1 TTD group 65 ± 12 82 ± 22† 78 ± 11† 74 ±11† 75 ± 15† 77 ± 14† 74 ± 11†
PAC group 71 ± 14 79 ± 12† 78 ± 11† 79 ± 14† 75 ± 15 77 ± 13 80 ± 13†
TTD: transpulmonary thermodilution; PAC: pulmonary artery catheter; CVP: central venous pressure; PAOP: pulmonary artery occlusion pressure; GEDVI:
global end-diastolic volume index; EVLWI: extravascular lung water index; MAP: mean arterial pressure; SVRI: systemic vascular resistance index; HR: heart
rate.
∗P<0.05 between the groups; †P<0.05 within the group compared with the preoperative value. Data are presented as mean ± SD.
Table 3: Changes in oxygenation and laboratory parameters in the study groups.
Parameter Group Before
surgery
End of
surgery 2hrs 6hrs 12hrs 18hrs 24hrs
PaO2/FiO2,m mH g TTD group 330 ± 104 269 ± 129† 322 ± 124 329 ± 102 337 ± 137 311 ± 114 291 ± 82
PAC group 279 ± 114 234 ± 89 286 ± 96 325 ± 87 324 ± 76 309 ± 101 310 ± 134
ScvO2,% TTD group 73 ± 10 71 ± 15 69 ± 10 66 ± 14 69 ± 11∗ 65 ± 14† 66 ± 8†
PAC group 70 ± 97 8 ± 10† 74 ± 10 75 ± 10 75 ± 14† 67 ± 14 65 ± 9
pH TTD group 7.39 ±0.04 7.34 ±0.01† 7.35 ±0.04† 7.34 ±0.07† 7.35 ±0.07† 7.38 ±0.05 7.41 ±0.05†
PAC group 7.38 ±0.05 7.34 ±0.05† 7.33 ±0.06† 7.38 ±0.05 7.39 ±0.05 7.42 ±0.05† 7.43 ±0.04†
Lactate, mmol L−1 TTD group 0.9 ±0.32 .8 ±1.0† 2.2 ±1.1† 3.3 ±2.1† 3.6 ±2.2† 2.5 ±1.6† 2.2 ±1.1†
PAC group 0.9 ±0.33 .0 ±0.9† 2.5 ±1.2† 3.5 ±2.1† 4.0 ±2.6† 2.5 ±1.2† 2.1 ±0.6†
Hb, g dL−1 TTD group 12.7 ±1.99 .0 ±1.4† 10.1 ±2.1† 10.5 ±1.7† 11.1 ±1.3† 11.0 ±1.5† 10.9 ±1.3†
PAC group 11.7 ±1.48 .4 ±1.2† 9.6 ±2.0† 10.5 ±1.4† 10.7 ±1.4† 10.6 ±1.2† 10.6 ±1.7†
Glucose, mmol L−1 TTD group 5.8 ±2.07 .3 ±3.27 .6 ±3.71 1 .9 ±4.1† 12.0 ±6.9† 8.7 ±2.2† 7.8 ±3.1
PAC group 5.8 ±1.78 .5 ±4.3† 8.4 ±3.4† 10.3 ±3.9† 12.8 ±4.7† 9.3 ±3.7† 8.6 ±5.5†
TTD: transpulmonary thermodilution; PAC: pulmonary artery catheter; PaO2: partial arterial oxygen pressure; FiO2: fraction of inspired oxygen; ScvO2:
central venous oxygen saturation; Hb: hemoglobin.
∗P<0.05 between the groups; †P<0.05 within the group compared with the preoperative value. Data are presented as mean ± SD.
the TTD and the PAC groups, respectively. At 24hrs after
surgery,therewasatrendtowardsincreasedcreatininevalues
in the PAC group (0.148 ± 0.02mmolL−1 versus 0.125 ±
0.03mmolL−1) in the TTD group (P = 0.08).
3.3. Clinical Characteristics and Outcomes. The clinical char-
acteristics and outcomes are presented in Table 4.
Although the volume of crystalloids administered during
surgery did not diﬀer signiﬁcantly between the groups, the
TTD group received 24% more crystalloids and a threefold
more colloids postoperatively (P<0.05). The total volume
of postoperative ﬂuid therapy in this group exceeded that
of the PAC group by 20% (P = 0.01). The incidence of
colloid administration and the postoperative ﬂuid balance
tended to be higher in the TTD group; by contrast, the
incidence and duration of inotropic/vasopressor support in
this group demonstrated a trend towards lower doses as
compared to the PAC-monitored patients. The incidence of
diuretic administration, postoperative diuresis, blood loss
and transfusion requirements, and the SOFA score at 24hrs
did not diﬀer between the groups. The rate of pericardial
pacing was similar: 70% and 60% in the PAC group and the
TTD group, respectively.
The requirement for renal replacement therapy was also
similar (one patient in each group). One patient in each
group presented with a postoperative stroke. There was no
wound infection in the studied patient population.Critical Care Research and Practice 7
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Figure 3: Changes in cardiac index, stroke volume index and oxygen delivery in the study groups. CI: cardiac index; SVI: stroke volume
index; DO2I: oxygen delivery index. ∗P<0.05 between the groups; †P<0.05 within the group compared with the preoperative value. Data
are presented as mean ± SD.
Duration of postoperative respiratory support increased
by 36% in the PAC group (Table 4, P = 0.04). However, the
duration of ICU stay and hospitalization did not diﬀer. All
the patients included in the study survived at Day 28.
4. Discussion
The study demonstrates that transpulmonary thermodilu-
tion combined with continuous monitoring of oxygen deliv-
ery may be used for detection of disorders in hemodynamics
and oxygen transport that might inﬂuence the perioperative
therapy after complex valve surgery.
Complex valve repair results in signiﬁcant changes in
preload. In this study, we found an increase in CVP after
CPB in both groups, which is typical for these cardiac inter-
ventions [22]. In the TTD group, GEDVI rose after surgery
in parallel with increased ﬂuid therapy, whereas EVLWI
declined. This ﬁnding can be explained by inclusion of col-
loids according to the treatment algorithm and by the rise in
myocardial performance following valve repair. Postopera-
tively, the patients in the PAC group displayed decreases
in the CVP and PAOP values. The reduction in these pre-
load parameters may be caused by several mechanisms: by
discontinuation of mechanical ventilation with PEEP and
restoration of spontaneous breathing; for the second, from
increased heart performance, and ﬁnally, from the relatively
restrictive ﬂuid regimen in the PAC group. The increase of
SVV that we observed in patients of the TTD group at the
end of the ﬁrst postoperative day may be explained mainly
by cessation of respiratory support. These results correspond
with other studies of goal-directed therapy in cardiac surgery
[12, 19, 23, 24].
At the end of surgery, we found lower MAP and SVRI
values in the PAC group. Systemic vasodilatation can be
explainedbytheCPB-inducedSIRSthatmightbeattenuated
by the TTD-driven ﬂuid therapy including colloids [11, 25].
In contrast to the TTD group, the patients of the PAC group
presented with systemic vasoconstriction postoperatively, as
evidenced by the increase in SVRI, which we interpret as a
compensatory mechanism counteracting the reduced blood
volume [26].
In addition to the changes in afterload, both groups had
increased postoperative heart rate and myocardial contrac-
tility that is conﬁrmed by an increase in CI and SVI. These
changes can be caused by correction of the valvular malfunc-
tions, restoration of myocardial function and hemodilution
in parallel with ﬂuid therapy [27]. Despite the transient peri-
operativechangesinarterialandcentralvenousoxygenation,8 Critical Care Research and Practice
Table 4: Clinical characteristics of the study groups.
Characteristic TTD group PAC group P value
Crystalloids intraoperatively, mL 1290 ± 213 1158 ± 327 0.14
Crystalloids during 24hrs postoperatively, mL 1875 ± 531 1518 ± 410 0.02
Colloids during 24hrs postoperatively, mL 250 ± 68 75 ± 41† 0.04
Incidence of colloid administration 15% 45% 0.08
Fluids during 24hrs postoperatively, mL 1850 (1600–2575) 1550 (1312–1700) 0.01
Incidence of inotropic/vasopressor support 35% 65% 0.11
Duration of inotropic/vasopressor support
after operation, hrs 11.9 ±4.61 7 .1 ±3.80 . 1 4
Incidence of diuretic administration 30% 55% 0.20
Fluid balance at 24hrs postoperatively, mL 85 (−358–940) −743 (−1275–196) 0.05
Diuresis at 24hrs postoperatively, mL 2410 ± 1196 2439 ± 959 0.93
Postoperative drainage blood loss, mL 557 ± 108 584 ± 190 0.21
SOFA score at 24hrs postoperatively, points 5 ± 16 ± 10 . 3 7
Duration of respiratory support, hrs 14.3 ±5.11 9 .4 ±5.8 0.04
Length of ICU stay, hrs 61.5 ±37.26 4 .1 ±37.80 . 7 0
Length of hospital stay, days 20.7 ±7.82 2 .0 ±7.80 . 6 0
TTD: transpulmonary thermodilution; PAC: pulmonary artery catheter. Data are presented as %, mean ± SD or median (25th–75th percentiles).
we observed an increase in oxygen delivery in parallel with
regressofmetabolicacidosisat24hrspostoperativelyinboth
groups.Theseresultsconﬁrmtheeﬃcacyofthegoal-directed
hemodynamic optimization. Therapy that increased oxygen
transport attenuates the surgical stress and the hypoperfu-
sion following combined CPB and valve repair [28]. In our
investigation, this stress was manifested by hyperglycemia, a
rise in NT-proBNP, and increase in plasma lactate in both
groups. Similar ﬁndings have been described by other au-
thors who assessed the eﬀects of CPB and combined valve
surgery [29, 30].
The preload optimization following valve repair in the
TTD group might have contributed to an increase in heart
performance with higher SVI compared with the PAC group.
Similar results were obtained by Hofer et al. in a general ICU
population [31] and by Brock et al. in patients undergoing
cardiac surgery [32]. As a result of goal-directed therapy,
the patients in the TTD group received more crystalloids
and colloids and tended to receive less inotropic and vaso-
pressor agents postoperatively. In cardiosurgical patients,
similar results have been reported [19, 33]. Correction of
hypovolaemia and cardiac output according to the study
algorithm resulted in a better oxygen delivery and reduced
the duration of respiratory support in the TTD group. These
ﬁndings are consistent with beneﬁcial eﬀects of goal-directed
therapy both in coronary and general surgery patients [15,
18, 19].
The observed intergroup diﬀerences might not result
solely from the net volume of ﬂuids but also from the accu-
racy of hemodynamic parameters used for preload assess-
ment. Indeed, PAOP has been demonstrated to have a limita-
tion as a preload marker [34]. In contrast, GEDVI is a more
reliable marker of preload indicating the ﬁlling volume of all
heart chambers, while PAOP barely reﬂects ﬁlling pressure of
the left atrium [35].
Perioperative goal-directed therapy should be early,
adequate, and individualized. Maintaining “supranormal”
cardiac output and oxygen delivery does not improve the
clinical outcome [36], thus we targeted to keep DO2Iv a l u e s
within the range of 400–600mLmin−1m−2. Although one of
the aims of our treatment algorithms in both groups was to
maintain CI > 2.0Lmin−1m−2, we did not reach mean DO2I
values > 400mLminm−2 in the PAC group. Interestingly,
despite lower oxygen delivery, mean ScvO2at 12hrs was
higher in the PAC group, which might indicate decreased
oxygen consumption. Thus, although CI and ScvO2 are
important determinants of oxygen transport in high-risk pa-
tients, they should be accompanied by assessment of DO2I
for the most eﬃcient guidance of postoperative care. More-
over, some conditions such as severe pulmonary hyperten-
sion might require simultaneous measurement of both vol-
umetric parameters and pulmonary arterial pressures, using
either PAC catheter or echocardiography for optimization of
the hemodynamic management.
Better oxygen transport might inﬂuence organ function
and improve clinical outcome. In our study, the PAC group
tended to present with increased plasma creatinine concen-
trationspostoperatively.Thisgroupreceivedlessﬂuid,which
possibly contributed to hypoperfusion and impaired renal
function [37]. Other investigators have demonstrated that
perioperative goal-directed therapy may have a protective
eﬀect on organ function, reducing the number of complica-
tions and even decreasing mortality, especially in high-risk
patients [16, 18, 38].
This study has several limitations related to the dif-
ferences in study algorithms. Firstly, we did not measure
PAOP in the TTD group or GEDVI in the PAC group. The
reason was that the possibility for the attending physician
to evaluate the volumetric parameters in the PAC group
and the PAC-derived variables in the TTD group could haveCritical Care Research and Practice 9
inﬂuenced the choice of ﬂuid therapy. Secondly, in the PAC
group, in contrast to the TTD group, DO2I was determined
intermittently and was not included in the algorithm of goal-
directed therapy. However, although the oxygen transport
in the TTD group was monitored continuously, it required
calibration with discrete measurement of blood gases at the
same time points like in the PAC group. Moreover, this
single-centrestudyhasalimitednumberofobservations and
was not powered for demonstrating the reduction in ICU
and hospital stay in the TTD group.
5. Conclusions
As compared to a PAC-guided treatment algorithm, goal-
directed therapy based on transpulmonary thermodilution
combined with monitoring of oxygen transport changes
the strategy of ﬂuid management, which in turn, improves
hemodynamics and oxygen delivery and reduces the dura-
tion of postoperative respiratory support after complex valve
surgery.
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